Tissue Regeneration Therapeutics Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Grant
  • Financing Rounds
  • 3

Tissue Regeneration Therapeutics General Information

Description

Operator of a biotechnology company focused on the development of human umbilical cord perivascular cells (HUCPVC) platform and other cell therapy products. The company's cell products, which include mesenchymal stem cells (MSCs) have regenerative, angiogenic, anti-inflammatory and immunoregulatory properties, enabling clinical-scientific groups to use it in their pre-clinical research for a variety of indications.

Contact Information

Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Primary Industry
Biotechnology
Primary Office
  • 790 Bay Street, Suite 512
  • Post Box 55
  • Toronto, Ontario M5G 1N8
  • Canada
+1 (416) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tissue Regeneration Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a biotechnology company focused on the development of human umbilical cord perivascular cells (HUCPVC) platf
Biotechnology
Toronto, Canada
10 As of 2015
0000000000

000

onsectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut en
0000000000000
Allendale, NJ
00.00
00.00 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tissue Regeneration Therapeutics Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000 Formerly PE-Backed Allendale, NJ 00.00 000000&0
You’re viewing 1 of 1 competitors. Get the full list »

Tissue Regeneration Therapeutics Patents

Tissue Regeneration Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190134101-A1 Genetically modified human umbilical cord perivascular cells for wound healing Pending 15-Jun-2016 000000000
US-20190125804-A1 Anti-cancer use of genetically modified human umbilical cord perivascular cells (hucpvc) Pending 15-Jun-2016 000000000
CA-2775779-A1 Porous materials coated with calcium phosphate and methods of fabrication thereof Abandoned 28-Sep-2009 000000000
US-20110076396-A1 Method of forming a calcium phosphate coating within a porous material Abandoned 28-Sep-2009 000000000
US-20120270031-A1 Porous materials coated with calcium phosphate and methods of fabrication thereof Abandoned 28-Sep-2009 C23C26/00 0

Tissue Regeneration Therapeutics Board Members (2)

Name Representing Role Since
000000 00000000 00.0 Tissue Regeneration Therapeutics Co-Founder and Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Tissue Regeneration Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tissue Regeneration Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tissue Regeneration Therapeutics‘s full profile, request access.

Request a free trial